What is SGMO's dilution risk score?

SGMO has a latest available DilutionScore record of 42/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for SGMO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for SGMO?

DilutionWatch tracks 25 SEC filing types for SGMO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SGMO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SGMO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SGMO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SGMO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SGMO Dilution Risk Score: 42/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

65

📊 Float Risk

2

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 42%

🔄 Reverse Split model est. 65%

• 50-day avg $0.22 below $1 exchange minimum

• 9 months cash with weak price

💰 Capital Raise model 33%

• Under 12 months cash (9mo)

• Active ATM program with $131M remaining capacity

🔔 Track SGMO — Get forecast alerts →

Market Data

Market Cap$91.14M

Shares Outstanding414.29M

Float410.04M

Cash$121.97M

Debt$19.33M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 92.1% shares (2026Q1 vs prior)

114 institutional holders · 122.97M shares

#1 ARMISTICE CAPITAL, LLC 40.40M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 25.41M shares

#3 TWO SIGMA INVESTMENTS, LP 6.27M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2025-09-30

4 INSIDER TRANSACTION 2026-04-23

4 INSIDER TRANSACTION 2026-04-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual SGMO Dilution Snapshot

Sangamo Therapeutics, Inc. (SGMO) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $131.2M.
Recent SEC activity tracked for SGMO: 4 on 2026-04-23; 4 on 2026-04-23; 4 on 2026-04-03.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.